Glutaraldehyde-mediated tissue crosslinking

Glutaraldehyde-mediated tissue crosslinking is a widely used chemical fixation process that stabilizes biological tissues and protein structures, especially those rich in collagen, by forming covalent cross-links between amino acid residues—most commonly lysines—using glutaraldehyde. In biomedical applications, this method is crucial for preparing bioprosthetic implants (such as heart valves) and stabilizing tissue samples for microscopy and histology[1][3][5]. The crosslinking increases tissue mechanical strength, reduces antigenicity and susceptibility to enzymatic degradation, and improves durability[1][3][4][5]. The process is non-specific, can have unintended effects on tissue flexibility, and is associated with potential long-term complications like calcification and inflammation if remnants of glutaraldehyde remain in the tissue[1]. As this is a procedural technique rather than a discrete molecular entity, it is incorrect to refer to "tissue crosslinking by glutaraldehyde" as a molecular target for drug development or pharmacological intervention.

Other names

Glutaraldehyde crosslinkingGA fixationGlutaraldehyde tissue fixationGlutaraldehyde-induced cross-linking

Formation of covalent bonds between primary amine groups (mostly lysine residues) via Schiff base intermediates, leading to protein cross-links[1][3][4][5] Polymerization of glutaraldehyde at high concentrations creates larger crosslinked networks[1][3][4][5]